GSK Hungary

GlaxoSmithKline - one of the world's leading research-driven pharmaceutical and health care companies - is committed to improving the quality of life for people. Leading role in the vaccinations, and infections of the central nervous system and respiratory diseases. The group's total domestic sales of Hungary's largest company among the two hundred.



Key therapeutic areas: asthma and COPD, thrombosis, infections (antibiotics and other respiratory infections), central nervous system diseases (epilepsy, Parkinson's disease, depression, migraine), and cancer. In addition, priority to preventing disease through immunization.

GSK research-driven company of the other highlights are particularly promising research and development portfolio, thanks. In addition, an important task to keep the parts of the world's poorer access to medicines. Particular attention is paid on investment is carried out in a few years ago was handed over by one of Hungary's largest pharmaceutical investment, a vaccine plant in Godollo.
In 2003, starting with an investment of more than 100 million vaccine manufacturing is one built on the company's key strategic investments in Europe. The new production base in the latest technologies to use, vakcináit Worldwide supplies, such as GSK is one of Hungary's biggest biotech exporter becomes.

In terms of market share by GlaxoSmithKline is the world's second largest pharmaceutical company, 6.3% share of the global pharmaceutical market to. In 2009, GSK 4.1 billion pounds sterling spent on research and development, a day * 11.2 million pounds has been invested for further development. Our mission is to improve the quality of human life, enabling people to do more for themselves , feel better and to live a longer life:

Type: NORMAL
Address: Budapest 1124 Csörsz u. 43. MOM Park Budapest 1124 Csörsz u. 43. MOM Park Gesztenyés Torony Phone: 225-5300 Fax: 225-5302 E-mail: gyorgy.l.leitner@gsk.com http://www.gsk.hu/ Budapest 1124 Csörsz
Website: https://www.gsk.hu
Phone: +36-1-225 5300
Fax: +36 225 5405
Email: reka.h.szalkai@gsk.com
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.